← Back to Search

Behavioural Intervention

SAS20 for Spinal Cord Injury

Phase 2
Waitlist Available
Research Sponsored by Kathleen Friel
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, immediately after intervention
Awards & highlights

Summary

The purpose of this study is to determine if spinal excitability is increased with a Spinal Associative Stimulation (SAS) protocol, and to determine the functional consequences of this technique on motor recovery.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, immediately after intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, immediately after intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in H-Reflex Threshold
Secondary study objectives
10 Meter Walk Test
Anklebot
Lower Extremity
+3 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: SAS20Experimental Treatment1 Intervention
The paired stimulation (SAS) will be comprised of patient adjusted subthreshold TMS (80% of resting motor threshold over optimal site for soleus muscle), delivered 20ms prior to a peripheral nerve stimulus in the popliteal fossa and will be repeated at 0.1 Hz for 15 minutes (90 stimuli pairs).
Group II: SAS0Active Control1 Intervention
The paired stimulation (SAS) will be comprised of patient adjusted subthreshold TMS (80% of resting motor threshold over optimal site for soleus muscle), delivered 0ms prior to a peripheral nerve stimulus in the popliteal fossa and will be repeated at 0.1 Hz for 15 minutes (90 stimuli pairs).
Group III: SAS50Active Control1 Intervention
The paired stimulation (SAS) will be comprised of patient adjusted subthreshold TMS (80% of resting motor threshold over optimal site for soleus muscle), delivered 50ms prior to a peripheral nerve stimulus in the popliteal fossa and will be repeated at 0.1 Hz for 15 minutes (90 stimuli pairs).

Find a Location

Who is running the clinical trial?

Kathleen FrielLead Sponsor
1 Previous Clinical Trials
40 Total Patients Enrolled
Burke Medical Research InstituteOTHER
23 Previous Clinical Trials
1,435 Total Patients Enrolled
Kathleen Friel, PhDStudy DirectorBurke Medical Research Institute
4 Previous Clinical Trials
122 Total Patients Enrolled
~2 spots leftby Sep 2025